.START 

G.D. Searle & Co. said the Food and Drug Administration approved the sale of Kerlone, a hypertension drug developed by a joint venture between Searle and a French concern. 

Searle, a unit of Monsanto Co., said the "beta-blocker" high-blood-pressure drug Kerlone is the first product to reach the market through Lorex Pharmaceuticals, the U.S. company jointly owned by Searle and Synthelabo, a French pharmaceutical concern owned by France's L'Oreal S.A. 

